Multiple Sclerosis – Modus Health

PUBLICATIONS

C. M. McDonald. Physical activity, health impairments, and disability in neuromuscular disease. Am J Phys Med Rehabil 2002; 81(11 Suppl):S108-20.

D. Gijbels, G. Alders, E. Van Hoof, et al. Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures. Mult Scler 2010; 16(5):618-26.

M. E. Busse, O. R. Pearson, R. Van Deursen, C. M. Wiles. Quantified measurement of activity provides insight into motor function and recovery in neurological disease. J Neurol Neurosurg Psychiatry 2004; 75(6):884-8.

A. Neven, A. Vanderstraeten, D. Janssens, G. Wets, P. Feys. Understanding walking activity in multiple sclerosis: step count, walking intensity and uninterrupted walking activity duration related to degree of disability. Neurol Sci 2016; 37(9):1483-90.

T. R. Brown, V. I. Simnad. A Randomized Crossover Trial of Dalfampridine Extended Release for Effect on Ambulatory Activity in People with Multiple Sclerosis. Int J MS Care 2016; 18(4):170-6.

B. M. Sandroff, R. W. Motl, L. A. Pilutti, et al. Accuracy of StepWatch and ActiGraph accelerometers for measuring steps taken among persons with multiple sclerosis. PLoS One 2014; 9(4):e93511.

R. W. Motl, Y. C. Learmonth. Neurological disability and its association with walking impairment in multiple sclerosis: brief review. Neurodegener Dis Manag 2014; 4(6):491-500.

K. J. Nolan, M. Yarossi, A. Ramanujam. Measuring ambulation in adults with central neurologic disorders. Phys Med Rehabil Clin N Am 2013; 24(2):247-63.

P. Filipovic Grcic, M. Matijaca, I. Bilic, et al. Correlation analysis of visual analogue scale and measures of walking ability in multiple sclerosis patients. Acta Neurol Belg 2013.

R. W. Motl, B. M. Sandroff, J. J. Sosnoff. Commercially available accelerometry as an ecologically valid measure of ambulation in individuals with multiple sclerosis. Expert Rev Neurother 2012; 12(9):1079-88.